SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-059381
Filing Date
2024-03-05
Accepted
2024-03-05 17:00:41
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d763500d424b5.htm 424B5 444038
2 EX-FILING FEES d763500dexfilingfees.htm EX-FILING FEES 16736
3 GRAPHIC g763500g84y11.jpg GRAPHIC 23100
4 GRAPHIC g763500g93n01.jpg GRAPHIC 50821
  Complete submission text file 0001193125-24-059381.txt   563937
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275548 | Film No.: 24721917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)